{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:11:08Z","timestamp":1768583468535,"version":"3.49.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2013.01.029","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T18:46:51Z","timestamp":1359485211000},"page":"1656-1665","source":"Crossref","is-referenced-by-count":20,"title":["Systematic review of economic evaluation studies: Are vaccination programs efficient in Spain?"],"prefix":"10.1016","volume":"31","author":[{"given":"Anna","family":"Garc\u00eda-Alt\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.01.029_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S1135-57272009000100011","article-title":"Relaci\u00f3n en Espa\u00f1a entre la investigaci\u00f3n sanitaria financiada por el Sistema Nacional de Salud y la carga de enfermedad en la comunidad","volume":"83","author":"Catal\u00e1-L\u00f3pez","year":"2009","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0010","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0264-410X(98)80107-2","article-title":"Global progress in infectious disease control","volume":"16","author":"Hinman","year":"1998","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.01.029_bib0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1377\/hlthaff.2011.0381","article-title":"During the \u2018decade of vaccines\u2019, the lives of 6. 4 million children valued at $231 billion could be saved","volume":"30","author":"Ozawa","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.vaccine.2013.01.029_bib0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1377\/hlthaff.2011.0382","article-title":"Estimated economic benefits during the \u2018decade of vaccines\u2019 include treatment savings, gains in labor productivity","volume":"30","author":"Stack","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0025","series-title":"The economics of infectious disease","author":"Roberts","year":"2006"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2013.01.029_bib0030","first-page":"143","article-title":"Economic evaluation of interventions for infectious diseases in Spain: systematic review and comparative analysis","volume":"24","author":"Catal\u00e1-L\u00f3pez","year":"2011","journal-title":"Rev Esp Quimioter"},{"issue":"10","key":"10.1016\/j.vaccine.2013.01.029_bib0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/11312720-000000000-00000","article-title":"30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement","volume":"27","author":"Neumann","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.vaccine.2013.01.029_bib0040","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1157\/13096592","article-title":"Construcci\u00f3n de un filtro geogr\u00e1fico para la identificaci\u00f3n en PubMed de estudios realizados en Espa\u00f1a","volume":"59","author":"Valderas","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0045","series-title":"The global burden of disease","author":"Murray","year":"1996"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1472-6963-11-75","article-title":"Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?","volume":"11","author":"Catal\u00e1-L\u00f3pez","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0055","unstructured":"Instituto Nacional de Estad\u00edstica. Products and Services\/The CPI in one click\/Do you wish to update a rental income? <http:\/\/www.ine.es\/calcula\/> [last accessed: 02.10.12]."},{"issue":"5","key":"10.1016\/j.vaccine.2013.01.029_bib0060","first-page":"409","article-title":"The cost-effectiveness of pneumococcal vaccination in Catalonia","volume":"69","author":"Plans Rubi\u00f3","year":"1995","journal-title":"Rev Esp Salud Publica"},{"issue":"5","key":"10.1016\/j.vaccine.2013.01.029_bib0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0213-9111(02)71948-1","article-title":"Cost-effectiveness of 23-valent antipneumococcical vaccination in Catalonia (Spain)","volume":"16","author":"Plans","year":"2002","journal-title":"Gac Sanit"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.029_bib0070","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/313977","article-title":"Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries","volume":"31","author":"Ament","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.01.029_bib0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10096-007-0327-z","article-title":"Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries","volume":"26","author":"Evers","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1524-4733.2004.71263.x","article-title":"A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain","volume":"7","author":"Asensi","year":"2004","journal-title":"Value Health"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2013.01.029_bib0085","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0264-410X(98)00394-6","article-title":"A cost benefit analysis of routine varicella vaccination in Spain","volume":"17","author":"D\u00edez Domingo","year":"1999","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2013.01.029_bib0090","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2005.01.018","article-title":"Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain)","volume":"23","author":"Navas","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0095","first-page":"193","article-title":"Cost-effectiveness analysis of pneumococcal vaccination in the elderly Spanish population","volume":"10","author":"Jim\u00e9nez","year":"1996","journal-title":"Br J Med Econ"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1576-9887(02)70289-6","article-title":"Infecci\u00f3n neumoc\u00f3cica en el Complejo Universitario Juan Canalejo: an\u00e1lisis coste\/beneficio de una pol\u00edtica de inmunizaci\u00f3n al alta hospitalaria","volume":"3","author":"Lema Devesa","year":"2002","journal-title":"Vacunas"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.01.029_bib0105","first-page":"23","article-title":"Coste-utilidad de la incorporaci\u00f3n de las nuevas vacunas antineumoc\u00f3cicas conjugadas al programa de vacunaci\u00f3n de la comunidad de Madrid. Impacto sobre la enfermedad neumoc\u00f3cica invasora","volume":"11","author":"Picazo","year":"2010","journal-title":"Vacunas"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.029_bib0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.gaceta.2011.03.006","article-title":"Cost-effectiveness analysis of pneumococcal vaccination in Spain","volume":"25","author":"Morano","year":"2011","journal-title":"Gac Sanit"},{"issue":"7","key":"10.1016\/j.vaccine.2013.01.029_bib0115","first-page":"400","article-title":"Human papilomavirus tetravalent vacciones cost-effectiveness study","volume":"6","author":"L\u00f3pez Alemany","year":"2007","journal-title":"Rev Esp Econ Salud"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1576-9887(08)71915-0","article-title":"An\u00e1lisis de coste-efectividad de la vacunaci\u00f3n frente al virus del papiloma humano tipos 6, 11, 16 y 18 en Espa\u00f1a","volume":"9","author":"Largeron","year":"2008","journal-title":"Vacunas"},{"issue":"16","key":"10.1016\/j.vaccine.2013.01.029_bib0125","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.ejca.2010.06.016","article-title":"Cost-effectiveness of human papillomavirus vaccination and screening in Spain","volume":"46","author":"Diaz","year":"2010","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2013.01.029_bib0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0304-5013(08)72326-4","article-title":"Impact of the human papilloma virus (HPV) quadrivalent (types 6\/11\/16\/18) vaccine in HPV-associated diseases in Spain","volume":"51","author":"Castellsagu\u00e9","year":"2008","journal-title":"Prog Obstet Ginecol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2013.01.029_bib0135","first-page":"166","article-title":"Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain","volume":"19","author":"Perez-Rubio","year":"2011","journal-title":"Infez Med"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/1471-2458-10-469","article-title":"Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain","volume":"10","author":"Diez-Domingo","year":"2010","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S1135-57272008000100009","article-title":"Social and economic impact of chicken pox vaccine at 15 months of age. Castile and Leon, Spain, 2004","volume":"82","author":"P\u00e9rez-Rubio","year":"2008","journal-title":"Rev Esp Salud Publica"},{"issue":"52","key":"10.1016\/j.vaccine.2013.01.029_bib0150","doi-asserted-by":"crossref","first-page":"9640","DOI":"10.1016\/j.vaccine.2011.10.038","article-title":"Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)","volume":"29","author":"D\u00edez-Domingo","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0155","first-page":"115","article-title":"Economic evaluation of routine vaccination of 15 month old children against chicken-pox-zoster","volume":"23","author":"Forc\u00e9n","year":"2000","journal-title":"An Sist Sanit Navar"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0160","first-page":"9","article-title":"Evaluaci\u00f3n econ\u00f3mica de la vacunaci\u00f3n sistem\u00e1tica frente al virus de la varicela-z\u00f3ster","volume":"2","author":"Mart\u00ednez-Z\u00e1rate","year":"2005","journal-title":"PharmacoEconomics"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.029_bib0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0213-9111(04)72015-4","article-title":"Cost-effectiveness of varicella vaccination in Spanish adolescents","volume":"18","author":"Pe\u00f1a-Rey","year":"2004","journal-title":"Gac Sanit"},{"issue":"47\u201348","key":"10.1016\/j.vaccine.2013.01.029_bib0170","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2006.04.051","article-title":"Economic evaluation of varicella vaccination in Spain: results from a dynamic model","volume":"24","author":"Lenne","year":"2006","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2013.01.029_bib0175","first-page":"777","article-title":"Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)","volume":"94","author":"Gavira","year":"1990","journal-title":"Med Clin (Barc)"},{"issue":"16","key":"10.1016\/j.vaccine.2013.01.029_bib0180","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.vaccine.2007.01.038","article-title":"Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3\u201314 years from the provider and societal perspectives","volume":"25","author":"Navas","year":"2007","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2013.01.029_bib0185","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1016\/j.vaccine.2009.01.053","article-title":"Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3\u201314 years during the annual health examination in private paediatric offices","volume":"27","author":"Salleras","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0190","first-page":"1012","article-title":"An\u00e1lisis econ\u00f3mico del coste de la gripe aplicado a la provincia de Huesca","volume":"61","author":"Almuzara Sauras","year":"1987","journal-title":"Rev San Hig Pub"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.029_bib0195","first-page":"227","article-title":"Evaluaci\u00f3n econ\u00f3mica de la vacunaci\u00f3n antigripal por los servicios m\u00e9dicos de empresa","volume":"3","author":"Pradas","year":"2004","journal-title":"Rev Esp Econ Salud"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.029_bib0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1157\/13087326","article-title":"Efficiency of influenza vaccination in the working population in Spain","volume":"20","author":"de Juanes","year":"2006","journal-title":"Gac Sanit"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.029_bib0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/S1135-57272006000300002","article-title":"Analysis of a economic model of a populational influenza immunization strategy in healthy employees","volume":"80","author":"Mart\u00edn Fern\u00e1ndez","year":"2006","journal-title":"Rev Esp Salud Publica"},{"issue":"39\u201340","key":"10.1016\/j.vaccine.2013.01.029_bib0210","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1016\/j.vaccine.2007.07.033","article-title":"The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain","volume":"25","author":"Aball\u00e9a","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.029_bib0215","first-page":"41","article-title":"A cost-effectiveness analysis of vaccination against the hepatitis B virus","volume":"99","author":"Anto\u00f1anzas","year":"1992","journal-title":"Med Clin (Barc)"},{"issue":"15","key":"10.1016\/j.vaccine.2013.01.029_bib0220","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0264-410X(97)00083-2","article-title":"Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis","volume":"15","author":"Garuz","year":"1997","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.029_bib0225","first-page":"130","article-title":"Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia","volume":"104","author":"Guill\u00e9n Grima","year":"1995","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0230","first-page":"611","article-title":"Cost-benefit analysis of a program for vaccination against hepatitis B in health personnel of a hospital","volume":"83","author":"Rivera","year":"1984","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.029_bib0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0266462300005754","article-title":"Cost-benefit analysis of hepatitis-B vaccination, A computerized decision model for Spain","volume":"7","author":"J\u00f6nsson","year":"1991","journal-title":"Int J Technol Assess Health Care"},{"issue":"17-18","key":"10.1016\/j.vaccine.2013.01.029_bib0240","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.vaccine.2005.01.065","article-title":"Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools","volume":"23","author":"Navas","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.029_bib0245","first-page":"265","article-title":"Comparison of two vaccination strategies against hepatitis A and B in patients with chronic hepatitis C","volume":"101","author":"D\u00edez Redondo","year":"2009","journal-title":"Rev Esp Enferm Dig"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.029_bib0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00019053-199712030-00008","article-title":"Cost-effectiveness of hepatitis A immunisation in Spain","volume":"12","author":"Arnal","year":"1997","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.029_bib0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1576-9887(01)70245-2","article-title":"An\u00e1lisis coste-efectividad de la inmunizaci\u00f3n frente al meningococo serogrupo C con vacuna conjugada","volume":"2","author":"Barricarte","year":"2001","journal-title":"Vacunas"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00019053-199915010-00005","article-title":"Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain","volume":"15","author":"Jim\u00e9nez","year":"1999","journal-title":"Pharmacoeconomics"},{"issue":"16","key":"10.1016\/j.vaccine.2013.01.029_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2334-9-65","article-title":"Effectiveness and economic analysis of the whole cell\/recombinant B subunit (WC\/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea","volume":"9","author":"L\u00f3pez-Gigosos","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.01.029_bib0270","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S0950268809991373","article-title":"Mathematical modeling of respiratory syncytial virus (RSV): vaccination strategies and budget applications","volume":"138","author":"Acedo","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2013.01.029_bib0275","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hec.608","article-title":"Twenty years of health care economic analysis in Spain: are we doing well?","volume":"10","author":"Garc\u00eda-Alt\u00e9s","year":"2001","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.029_bib0280","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1157\/13101044","article-title":"Health promotion: a profitable investment? Economic efficiency of preventive interventions in Spain","volume":"21","author":"Esperato","year":"2007","journal-title":"Gac Sanit"},{"issue":"4","key":"10.1016\/j.vaccine.2013.01.029_bib0285","first-page":"353","article-title":"Economic evaluation of healthcare interventions during more than 25 years in Spain (1983\u20132008)","volume":"84","author":"Catal\u00e1-L\u00f3pez","year":"2010","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0290","doi-asserted-by":"crossref","first-page":"JS1","DOI":"10.1097\/00005650-199307001-00001","article-title":"Health care CBA\/CEA: an update on the growth and composition of the literature","volume":"31","author":"Elixhauser","year":"1993","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0295","doi-asserted-by":"crossref","first-page":"MS1","DOI":"10.1097\/00005650-199805001-00001","article-title":"Health care CBA and CEA from 1991 to 1996: an updated bibliography","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"7 (Suppl. 1)","key":"10.1016\/j.vaccine.2013.01.029_bib0300","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/MLR.0b013e31819bc09d","article-title":"Costing and perspective in published cost-effectiveness analysis","volume":"47","author":"Neumann","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0305","series-title":"Propuesta de gu\u00eda para la evaluaci\u00f3n econ\u00f3mica aplicada a las tecnolog\u00edas sanitarias","author":"L\u00f3pez Bastida","year":"2008"},{"issue":"2","key":"10.1016\/j.vaccine.2013.01.029_bib0310","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gaceta.2009.07.011","article-title":"A proposed guideline for economic evaluation of health technologies","volume":"24","author":"L\u00f3pez Bastida","year":"2010","journal-title":"Gac Sanit"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S1135-57272009000100005","article-title":"De la utilidad de los medicamentos al valor terap\u00e9utico a\u00f1adido y a la relaci\u00f3n coste-efectividad incremental","volume":"83","author":"Puig-Junoy","year":"2009","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0320","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ypmed.2009.04.004","article-title":"The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low?","volume":"48","author":"Porta","year":"2009","journal-title":"Prev Med"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.01.029_bib0325","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ypmed.2009.02.011","article-title":"Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained","volume":"48","author":"Puig-Junoy","year":"2009","journal-title":"Prev Med"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2013.01.029_bib0330","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1016\/j.vaccine.2008.02.004","article-title":"Evolution of the health economics of cervical cancer vaccination","volume":"26","author":"Ferko","year":"2008","journal-title":"Vaccine"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2013.01.029_bib0335","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.vaccine.2007.04.070","article-title":"Do we fully understand the economic value of vaccines?","volume":"25","author":"Drummond","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.01.029_bib0340","first-page":"15","article-title":"The value of vaccination","volume":"6","author":"Bloom","year":"2005","journal-title":"World Economics"},{"issue":"November (19)","key":"10.1016\/j.vaccine.2013.01.029_bib0345","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMp1110539","article-title":"The role of cost-effectiveness in U.S. vaccination policy","volume":"365","author":"Kim","year":"2011","journal-title":"N Engl J Med"},{"issue":"October (27\u201330)","key":"10.1016\/j.vaccine.2013.01.029_bib0350","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/S0264-410X(03)00377-3","article-title":"The value of vaccination: a global perspective","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"issue":"9789","key":"10.1016\/j.vaccine.2013.01.029_bib0355","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(11)60406-6","article-title":"The future of immunisation policy, implementation, and financing","volume":"378","author":"Levine","year":"2011","journal-title":"Lancet"},{"issue":"9790","key":"10.1016\/j.vaccine.2013.01.029_bib0360","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(11)60678-8","article-title":"Addressing the vaccine confidence gap","volume":"378","author":"Larson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0365","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.38737.607558.80","article-title":"Bias in published cost effectiveness studies: systematic review","volume":"332","author":"Bell","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vaccine.2013.01.029_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199814010-00001","article-title":"Economic evaluation of pharmaceuticals: science or marketing?","volume":"14","author":"Drummond","year":"1998","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.vaccine.2013.01.029_bib0375","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11912-001-0027-2","article-title":"Conflict of interest in industry-sponsored economic evaluations: real or imagined?","volume":"3","author":"Barbieri","year":"2001","journal-title":"Curr Oncol Rep"},{"issue":"13","key":"10.1016\/j.vaccine.2013.01.029_bib0380","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/jama.2009.1409","article-title":"Using effectiveness and cost-effectiveness to make drug coverage decisions. A comparison of Britain, Australia, and Canada","volume":"302","author":"Clement","year":"2009","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.01.029_bib0385","first-page":"2","article-title":"An\u00e1lisis de las evaluaciones econ\u00f3micas de tecnolog\u00edas sanitarias realizadas en Espa\u00f1a en la d\u00e9cada 1990\u20132000","volume":"16","author":"Oliva","year":"2002","journal-title":"Gac Sanit"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0390","unstructured":"Asociaci\u00f3n Econom\u00eda de la Salud (AES). Posici\u00f3n de la Asociaci\u00f3n de Econom\u00eda de la Salud en relaci\u00f3n a la necesidad de un mayor uso de la evaluaci\u00f3n econ\u00f3mica en las decisiones que afectan a la financiaci\u00f3n p\u00fablica de las prestaciones y tecnolog\u00edas en el Sistema Nacional de Salud. <http:\/\/www.aes.es\/Publicaciones\/AESEE.pdf> [last accessed: 02.10.12]."},{"key":"10.1016\/j.vaccine.2013.01.029_bib0395","unstructured":"BOE. Bolet\u00edn Oficial del Estado. Ley 16\/2003, de 28 de mayo, de Cohesi\u00f3n y Calidad del Sistema Nacional de Salud. BOE n\u00fam. 128, de 29\/05\/2003."},{"key":"10.1016\/j.vaccine.2013.01.029_bib0400","unstructured":"BOE. Bolet\u00edn Oficial del Estado. Real Decreto 1030\/2006, de 15 de septiembre, por el que se establece la cartera de servicios comunes del Sistema Nacional de Salud y el procedimiento para su actualizaci\u00f3n. BOE n\u00fam. 222, de 16\/10\/2006."},{"key":"10.1016\/j.vaccine.2013.01.029_bib0405","series-title":"Plan de Calidad para el Sistema Nacional de Salud","author":"Ministerio de Sanidad y Consumo","year":"2007"},{"key":"10.1016\/j.vaccine.2013.01.029_bib0410","unstructured":"BOE. Bolet\u00edn Oficial del Estado. Real Decreto-ley 16\/2012, de 20 de abril, de medidas urgentes para garantizar la sostenibilidad del Sistema Nacional de Salud y mejorar la calidad y seguridad de sus prestaciones. BOE n\u00fam. 98, de 24\/4\/2012."},{"key":"10.1016\/j.vaccine.2013.01.029_bib0415","series-title":"Criterios para fundamentar la modificaci\u00f3n de los programas de vacunas","author":"Ministerio de Sanidad y Consumo","year":"2004"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T03:54:47Z","timestamp":1539921287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":83,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X13000868"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}